These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 15734201)

  • 41. Prostate high-dose-rate brachytherapy as salvage treatment of local failure after previous external or permanent seed irradiation for prostate cancer.
    Tharp M; Hardacre M; Bennett R; Jones WT; Stuhldreher D; Vaught J
    Brachytherapy; 2008; 7(3):231-6. PubMed ID: 18579446
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of the outcome and morbidity for localized or locally advanced prostate cancer treated by high-dose-rate brachytherapy plus external beam radiotherapy (EBRT) versus EBRT alone.
    Fang FM; Wang YM; Wang CJ; Huang HY; Chiang PH
    Jpn J Clin Oncol; 2008 Jul; 38(7):474-9. PubMed ID: 18621848
    [TBL] [Abstract][Full Text] [Related]  

  • 43. GEC-ESTRO ACROP prostate brachytherapy guidelines.
    Henry A; Pieters BR; André Siebert F; Hoskin P;
    Radiother Oncol; 2022 Feb; 167():244-251. PubMed ID: 34999134
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Brachytherapy boost techniques for locally advanced prostate cancer.
    Vicini FA; Kestin LL; Stromberg JS; Martinez AA
    Oncology (Williston Park); 1999 Apr; 13(4):491-9, 503; discussion 503-6, 509. PubMed ID: 10234701
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Implementation of high-dose-rate brachytherapy and androgen deprivation in patients with prostate cancer.
    Lilleby W; Tafjord G; Raabe NK
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):933-9. PubMed ID: 22138456
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A new model using number of needles and androgen deprivation to predict chronic urinary toxicity for high or low dose rate prostate brachytherapy.
    Vargas C; Ghilezan M; Hollander M; Gustafson G; Korman H; Gonzalez J; Martinez A
    J Urol; 2005 Sep; 174(3):882-7. PubMed ID: 16093980
    [TBL] [Abstract][Full Text] [Related]  

  • 47. GEC-ESTRO ACROP recommendations for head & neck brachytherapy in squamous cell carcinomas: 1st update - Improvement by cross sectional imaging based treatment planning and stepping source technology.
    Kovács G; Martinez-Monge R; Budrukkar A; Guinot JL; Johansson B; Strnad V; Skowronek J; Rovirosa A; Siebert FA;
    Radiother Oncol; 2017 Feb; 122(2):248-254. PubMed ID: 27889184
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High-dose-rate prostate brachytherapy: an excellent accelerated-hypofractionated treatment for favorable prostate cancer.
    Martinez AA; Demanes J; Vargas C; Schour L; Ghilezan M; Gustafson GS
    Am J Clin Oncol; 2010 Oct; 33(5):481-8. PubMed ID: 19952715
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Combined iridium 192 afterloading therapy of prostate carcinoma].
    Dinges S; Loening SA; Budach V
    Praxis (Bern 1994); 1997 Nov; 86(48):1908-11. PubMed ID: 9480511
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rectal bleeding after high-dose-rate brachytherapy combined with hypofractionated external-beam radiotherapy for localized prostate cancer: impact of rectal dose in high-dose-rate brachytherapy on occurrence of grade 2 or worse rectal bleeding.
    Akimoto T; Katoh H; Kitamoto Y; Tamaki T; Harada K; Shirai K; Nakano T
    Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):364-70. PubMed ID: 16690428
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical outcome in patients with prostate cancer treated with external beam radiotherapy and high dose-rate iridium 192 brachytherapy boost: a 6-year follow-up.
    Kälkner KM; Wahlgren T; Ryberg M; Cohn-Cedermark G; Castellanos E; Zimmerman R; Nilsson J; Lundell M; Fowler J; Levitt S; Hellström M; Nilsson S
    Acta Oncol; 2007; 46(7):909-17. PubMed ID: 17917823
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
    Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
    Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Urinary and rectal complications of contemporary permanent transperineal brachytherapy for prostate carcinoma with or without external beam radiation therapy.
    Sarosdy MF
    Cancer; 2004 Aug; 101(4):754-60. PubMed ID: 15305406
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High-dose-rate brachytherapy in the curative treatment of patients with localized prostate cancer.
    Pisansky TM; Gold DG; Furutani KM; Macdonald OK; McLaren RH; Mynderse LA; Wilson TM; Hebl JR; Choo R
    Mayo Clin Proc; 2008 Dec; 83(12):1364-72. PubMed ID: 19046556
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Irradiation of localized prostatic carcinoma with a combination of high dose rate iridium-192 brachytherapy and external beam radiotherapy with three target definitions and dose levels inside the prostate gland.
    Borghede G; Hedelin H; Holmäng S; Johansson KA; Sernbo G; Mercke C
    Radiother Oncol; 1997 Sep; 44(3):245-50. PubMed ID: 9380823
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A nomogram to compensate for intraoperative prostate edema during transperineal brachytherapy.
    Potters L; Wang XH; Yamada Y
    Tech Urol; 2000 Jun; 6(2):99-103. PubMed ID: 10798808
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The impact of brachytherapy on prostate cancer-specific mortality for definitive radiation therapy of high-grade prostate cancer: a population-based analysis.
    Shen X; Keith SW; Mishra MV; Dicker AP; Showalter TN
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1154-9. PubMed ID: 22270175
    [TBL] [Abstract][Full Text] [Related]  

  • 58. American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy.
    Davis BJ; Horwitz EM; Lee WR; Crook JM; Stock RG; Merrick GS; Butler WM; Grimm PD; Stone NN; Potters L; Zietman AL; Zelefsky MJ;
    Brachytherapy; 2012; 11(1):6-19. PubMed ID: 22265434
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effectiveness and side effects of conformal external beam radiotherapy combined with high-dose-rate brachytherapy boost compared to conformal external beam radiotherapy alone in patients with prostate cancer.
    Smolska-Ciszewska B; Miszczyk L; Białas B; Fijałkowski M; Plewicki G; Gawkowska-Suwińska M; Giglok M; Behrendt K; Nowicka E; Zajusz A; Suwiński R
    Radiat Oncol; 2015 Mar; 10():60. PubMed ID: 25884489
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [High-dose-rate brachytherapy of prostatic carcinoma with iridium 192].
    Schwarzer JU; Hofmann R; Kneschaurek P; Lukas P; Lindner A; Braun J
    Strahlenther Onkol; 1992 Jan; 168(1):17-22. PubMed ID: 1734585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.